Anti-Th17 Biobetter

by Anti-Th17 Biobetter
Published: July 23, 2022 (4 weeks ago)

The path of discovery of each therapeutic antibody is different. We focus on your antibody goals and work with you to achieve the ADCC/CDC enhancement goals. Whether you need expression optimization, recombinant protein production, antibody ADCC/CDC modification design, or cell line development, Creative Biolabs provides solutions to drive your research and accelerate your market.

Anti-Th17 Biobetter